These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38307733)

  • 1. Efficacy of canakinumab for mosaic tumor necrosis factor receptor associated periodic syndrome.
    Terré A; Vautier M; Kahn JE; Georgin-Lavialle S; Boursier G
    Eur J Intern Med; 2024 May; 123():156-158. PubMed ID: 38307733
    [No Abstract]   [Full Text] [Related]  

  • 2. Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
    La Torre F; Muratore M; Vitale A; Moramarco F; Quarta L; Cantarini L
    Rheumatol Int; 2015 Nov; 35(11):1943-7. PubMed ID: 26048626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delights and let-downs in the management of tumor necrosis factor receptor-associated periodic syndrome: the canakinumab experience in a patient with a high-penetrance T50M TNFRSF1A variant.
    Cantarini L; Lopalco G; Vitale A; Caso F; Lapadula G; Iannone F; Galeazzi M; Rigante D
    Int J Rheum Dis; 2015 May; 18(4):473-5. PubMed ID: 25522898
    [No Abstract]   [Full Text] [Related]  

  • 4. A Case Presenting with the Clinical Characteristics of Tumor Necrosis Factor (TNF) Receptor-associated Periodic Syndrome (TRAPS) without TNFRSF1A Mutations Successfully Treated with Tocilizumab.
    Hosoya T; Mizoguchi F; Hasegawa H; Miura K; Koike R; Kubota T; Miyasaka N; Kohsaka H
    Intern Med; 2015; 54(16):2069-72. PubMed ID: 26278305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor receptor-associated periodic syndrome in a pediatric patient: A genetic diagnosis.
    Yakhmi N; Knutsen AP
    Ann Allergy Asthma Immunol; 2020 Oct; 125(4):369-371. PubMed ID: 32376455
    [No Abstract]   [Full Text] [Related]  

  • 6. Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States.
    Hur P; Lomax KG; Ionescu-Ittu R; Manceur AM; Xie J; Cammarota J; Gautam R; Sanghera N; Kim N; Grom AA
    Pediatr Rheumatol Online J; 2021 Sep; 19(1):143. PubMed ID: 34521444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate.
    Lopalco G; Rigante D; Vitale A; Frediani B; Iannone F; Cantarini L
    Clin Rheumatol; 2015 Apr; 34(4):807-9. PubMed ID: 24609716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canakinumab for the treatment of TNF-receptor associated periodic syndrome.
    La Torre F; Caparello MC; Cimaz R
    Expert Rev Clin Immunol; 2017 Jun; 13(6):513-523. PubMed ID: 28454496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.
    De Benedetti F; Gattorno M; Anton J; Ben-Chetrit E; Frenkel J; Hoffman HM; Koné-Paut I; Lachmann HJ; Ozen S; Simon A; Zeft A; Calvo Penades I; Moutschen M; Quartier P; Kasapcopur O; Shcherbina A; Hofer M; Hashkes PJ; Van der Hilst J; Hara R; Bujan-Rivas S; Constantin T; Gul A; Livneh A; Brogan P; Cattalini M; Obici L; Lheritier K; Speziale A; Junge G
    N Engl J Med; 2018 May; 378(20):1908-1919. PubMed ID: 29768139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor receptor-associated periodic fever syndrome in a 58-year-old man: caution not to discount TRAPS as a diagnosis in older patients.
    Sinožić D; Toplak N; Milotić I
    J Clin Rheumatol; 2011 Sep; 17(6):325-8. PubMed ID: 21869706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of tumor necrosis factor receptor-associated periodic syndrome with canakinumab.
    Brizi MG; Galeazzi M; Lucherini OM; Cantarini L; Cimaz R
    Ann Intern Med; 2012 Jun; 156(12):907-8. PubMed ID: 22711098
    [No Abstract]   [Full Text] [Related]  

  • 12. Growth Parameters of Turkish Children With an Autoinflammatory Disease Before and After Canakinumab Treatment.
    Balci S; Ekinci RMK; Dogruel D; Altintas DU; Yilmaz M
    Indian Pediatr; 2020 Jul; 57(7):637-640. PubMed ID: 32727940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the diagnosis and treatment of tumor necrosis factor receptor-associated periodic syndrome.
    Aguado-Gil L; Irarrazaval-Armendáriz I; Pretel-Irazabal M
    Actas Dermosifiliogr; 2013 Sep; 104(7):617-22. PubMed ID: 23891452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor necrosis receptor associated periodic syndrome (TRAPS): State of the art].
    Georgin-Lavialle S; Kone-Paut I; Delaleu J; Sarrabay G; Grateau G; Touitou I; Hentgen V
    Rev Med Interne; 2018 Apr; 39(4):256-264. PubMed ID: 29525418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons from anti-TNF biologics: infliximab failure in a TRAPS family with the T50M mutation in TNFRSF1A.
    Nedjai B; Quillinan N; Coughlan RJ; Church L; McDermott MF; Hitman GA; Turner MD
    Adv Exp Med Biol; 2011; 691():409-19. PubMed ID: 21153346
    [No Abstract]   [Full Text] [Related]  

  • 16. The First Case of a Korean Patient with a Mutation-Confirmed Tumor Necrosis Factor Receptor-Associated Periodic Syndrome.
    Lee SJ; Baek JY; Lee JY; Kang JM; Ahn JG
    Yonsei Med J; 2024 Apr; 65(4):241-245. PubMed ID: 38515362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel TNFRSF1 gene mutation in a Turkish family: a report of three cases.
    Cosan F; Yazici A; Yılmazer B; Gul A; Ustek D; Cefle A
    Clin Rheumatol; 2013 Mar; 32 Suppl 1():S83-5. PubMed ID: 20532935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel TNFRSF1A gene mutation in a patient with tumor necrosis factor receptor-associated periodic syndrome.
    Khabazi A; Maralani M; Andalib S; Sakhinia E
    Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):175-177. PubMed ID: 27793577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosage Considerations for Canakinumab in Children With Periodic Fever Syndromes.
    Zhuang L; Chen J; Yu J; Marathe A; Sahajwalla C; Borigini M; Maynard J; Burckart GJ; Wang Y
    Clin Pharmacol Ther; 2019 Sep; 106(3):557-567. PubMed ID: 30447083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mosaic variants in TNFRSF1A: an emerging cause of tumour necrosis factor receptor-associated periodic syndrome.
    Assrawi E; Louvrier C; El Khouri E; Delaleu J; Copin B; Dastot-Le Moal F; Piterboth W; Legendre M; Karabina SA; Grateau G; Amselem S; Giurgea I
    Rheumatology (Oxford); 2022 Dec; 62(1):473-479. PubMed ID: 35640127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.